keyword
MENU ▼
Read by QxMD icon Read
search

Vedolizumab

keyword
https://www.readbyqxmd.com/read/28204866/vedolizumab-treatment-for-immune-checkpoint-inhibitor-induced-enterocolitis
#1
Viktoria Bergqvist, Erik Hertervig, Peter Gedeon, Marija Kopljar, Håkan Griph, Sara Kinhult, Ana Carneiro, Jan Marsal
Immune checkpoint inhibitors (ICPI), such as ipilimumab [anti-cytotoxic T-lymphocyte antigen-4 (CTLA-4) antibody] and nivolumab or pembrolizumab [anti-programmed cell death protein-1 (PD-1) antibodies], improve survival in several cancer types. Since inhibition of CTLA-4 or PD-1 leads to non-selective activation of the immune system, immune-related adverse events (irAEs) are frequent. Enterocolitis is a common irAE, currently managed with corticosteroids and, if necessary, anti-tumor necrosis factor-α therapy...
February 15, 2017: Cancer Immunology, Immunotherapy: CII
https://www.readbyqxmd.com/read/28178003/efficacy-and-safety-of-vedolizumab-for-induction-of-remission-in-inflammatory-bowel-disease-the-israeli-real-world-experience
#2
Uri Kopylov, Yulia Ron, Irit Avni-Biron, Benjamin Koslowsky, Matti Waterman, Saleh Daher, Bella Ungar, Henit Yanai, Nitsan Maharshak, Ofer Ben-Bassat, Lev Lichtenstein, Ariella Bar-Gil Shitrit, Eran Israeli, Doron Schwartz, Eran Zittan, Rami Eliakim, Yehuda Chowers, Shomron Ben-Horin, Iris Dotan
BACKGROUND: Vedolizumab (VDZ) is an anti-integrin monoclonal antibody effective in ulcerative colitis (UC) and Crohn's disease (CD). The aim of this study was to examine the "real world" efficacy and safety of VDZ in a large national patient cohort. METHODS: Patients with inflammatory bowel disease treated with VDZ were prospectively followed for 14 weeks. Patients who completed the induction protocol (week 0/2/6/14) or discontinued the treatment before week 14 for adverse events (AEs) or primary nonresponse were included...
February 7, 2017: Inflammatory Bowel Diseases
https://www.readbyqxmd.com/read/28175210/p544-combination-therapy-of-vedolizumab-and-a-tnf-antagonist-in-ibd-patients-with-severe-chronic-active-therapy-refractory-disease-course
#3
T Kuehbacher, R Abu Hashem, N Langel, S Schreiber, O Drvarov
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175174/p466-real-world-effectiveness-of-vedolizumab-over-one-year-in-inflammatory-bowel-disease-a-meta-analysis
#4
S Schreiber, A Dignass, L Peyrin-Biroulet, G Hather, D Demuth, J M Khalid, E V Loftus
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175160/p515-evaluation-of-treatment-persistence-of-vedolizumab-among-finnish-inflammatory-bowel-disease-patients-in-real-life-clinical-practice-finvedo
#5
T Ylisaukko-Oja, A Eberl, J Aaltonen, H Nuutinen, T Blomster, A Jussila, M Pajala, J Jokelainen, S Herrala, K Tamminen, T Sipponen
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175140/p361-machine-learning-models-at-week-6-of-vedolizumab-therapy-for-ulcerative-colitis-can-predict-week-52-corticosteroid-free-endoscopic-remission
#6
A Waljee, B Liu, K Sauder, J Zhu, S Govani, R W Stidham, P D Higgins
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175133/p525-effectiveness-and-safety-of-vedolizumab-in-ibd-patients-a-multicentre-experience-of-real-world-data-from-the-uk
#7
M V Lenti, S Levison, E Eliadou, R Willert, K Kemp, C Stansfield, A Assadsangabi, S Singh, B Crooks, S Tattersall, C Kenneth, S Subramanian, C Probert, P Smith, E Liu, J K Limdi, P J Hamlin, C P Selinger
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175118/p521-a-prospective-cohort-study-to-assess-the-relevance-of-vedolizumab-drug-level-monitoring-in-ibd-patients
#8
H Schulze, P Esters, F Hartmann, J Stein, C Christ, M Zorn, A Dignass
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175096/p445-perioperative-use-of-vedolizumab-seems-not-associated-with-short-term-postoperative-infectious-complications-in-patients-with-crohn-s-disease-undergoing-right-hemicolectomy-with-ileocolonic-anastomosis
#9
N Schils, A De Buck van Overstraeten, S Vermeire, G Van Assche, A Wolthuis, A D'Hoore, M Ferrante
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175093/p501-baseline-characteristics-of-crohn-s-disease-patients-in-the-vedolizumab-pass-study-a-cohort-study-assessing-the-safety-and-effectiveness-of-vedolizumab-compared-to-other-biologic-agents-02
#10
C A Siegel, G Lichtenstein, B Siegmund, J D Lewis, D Wolf, E Louis, S Sebastian, X Hebuterne, A Bell, C Söderman, S Schubert, R Atreya, S Polyak, S Hoque, A Krummenerl, B Bokemeyer, T Krummenerl, S Shulmann, P Karlén, B Moum, P Dolin
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175086/p410-vedolizumab-is-safe-and-effective-for-ibd-but-has-no-effect-on-liver-biochemistry-in-patients-with-concurrent-psc
#11
B Christensen, D Micic, P R Gibson, S Singh, E Bellaguarda, P Corsello, J N Gaetano, J Kinnucan, V L Rao, S Reddy, A Yarur, D T Rubin, J Pekow
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28174921/dop026-sustained-remission-with-vedolizumab-in-patients-with-moderately-to-severely-active-ulcerative-colitis-a-gemini-1-post-hoc-analysis-of-week-14-remitters
#12
A Stallmach, B Bokemeyer, J Axler, R Curtis, R Ehehalt, B Feagan, P Geransar, A James, A Kaviya, J M Khalid, D Wolf, S Schreiber
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172991/p647-tuberculosis-in-patients-treated-with-vedolizumab-clinical-trial-and-post-marketing-case-series
#13
M Zerôncio, A Blake, Q Rana-Khan, W Palo, F Bhayat
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172963/p617-extraintestinal-autoimmune-phenomena-during-treatment-with-vedolizumab
#14
D Lissner, E Sonnenberg, R Glauben, C Allers, J Preiss, T Schneider, C Loddenkemper, B Siegmund
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172960/p414-vedolizumab-in-pediatric-inflammatory-bowel-diseases-a-retrospective-multi-center-experience-from-the-paediatric-ibd-porto-group-of-espghan
#15
O Ledder, T de Meij, J Martín de Carpi, L Richmond, S Cohen, J Bronsky, R Shaoul, A Levine, J Escher, L deRidder, A Assa, F Ruemmele, N Shah, V Wolters, A Rodrigues, H Uhlig, D Urlep, C Posovsky, K Kolho, D Turner
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172955/p447-vedolizumab-induces-significantly-higher-endoscopic-remission-rates-at-week-16-in-ulcerative-colitis-as-compared-to-crohn-s-disease
#16
R W M Pauwels, A C De Vries, C J Van der Woude
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172936/p474-an-enzyme-linked-immunosorbent-assay-for-therapeutic-drug-monitoring-of-vedolizumab
#17
C Berger, J Semmler, J Ruppert, H Schulze, F-P Armbruster, A Dignass, J Stein
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172931/p514-combination-treatment-with-vedolizumab-and-anti-tnf-%C3%AE-in-inflammatory-bowel-disease-safety-data
#18
L Buer, M L Høivik, A W Medhus, B Moum
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172925/p391-differential-use-of-vedolizumab-in-ulcerative-colitis-and-crohn-s-disease-real-life-results-from-2-tertiary-referral-centres-in-the-united-kingdom
#19
N Kamperidis, A Cavazza, M Wahed, N Arebi
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172895/p442-incidence-of-pneumonia-and-other-respiratory-tract-infections-with-vedolizumab-treatment-for-inflammatory-bowel-disease-clinical-trial-experience
#20
B Feagan, F Bhayat, J M Khalid, W Palo, A Blake, M Shetzline, S Travis
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
keyword
keyword
1883
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"